Intelligence Β· Clinical Pipeline

Vanda Pharmaceuticals Netherlands Pipeline

All ClinicalTrials.gov programs at Vanda Pharmaceuticals Netherlands β€” phase, modality, and trial IDs.

Programs
3

Quick answer

Vanda Pharmaceuticals Netherlands has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Iloperidone

    Vanda Pharmaceuticals Netherlands B.V.

    Schizophrenia

    approved small molecule active

    5 trials
  2. iloperidone

    Vanda Pharmaceuticals Netherlands B.V.

    Bipolar Disorder

    approved small molecule completed

    1 trial
  3. tasimelteon 20 mg capsule

    Vanda Pharmaceuticals Netherlands B.V.

    Non-24-Hour-Sleep-Wake Disorder

    approved small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does Vanda Pharmaceuticals Netherlands have?

3 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs